Journey Medical (DERM) Deferred Taxes (2020 - 2021)
Journey Medical's (DERM) quarterly Deferred Taxes came in at $8.3 million in Q4 2021, up 2281.27% YoY from $347168.2 in Q4 2020, and up 351.51% on a QoQ basis from -$3.3 million in Q3 2021.
Journey Medical (DERM) Deferred Taxes (2020 - 2021) Analysis & Trends
Journey Medical (DERM) has 2 years of Deferred Taxes data on file, last reported at $8.3 million in Q4 2021.
- Quarterly Deferred Taxes rose 2281.27% year-over-year to $8.3 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.6 million (changed N/A YoY) and the FY2021 annual result came in at $1.6 million, up 567.46% from the prior year.
- Deferred Taxes climbed to $8.3 million in Q4 2021, from -$3.3 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $8.3 million in Q4 2021 to a low of -$3.5 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.82 Bn | 40.16 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 32.64 Bn | 30.96 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.38 Bn | 19.71 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.88 Bn | 17.99 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Journey Medical | 212.16 Mn | 186.51 Mn | 12.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 8.27 Mn |
| Sep 30, 2021 | -3.29 Mn |
| Jun 30, 2021 | -3.48 Mn |
| Mar 31, 2021 | 69,000.00 |
| Dec 31, 2020 | -379,000.00 |